Dr. Farhad Arjomand, MD

Dr. Arjomand practices at Newyork-Presbyterian Medical Group/Westchester in Yorktown Heights, New York.

Dr. Arjomand's NPI, 1578679031, was assigned on August 21, 2006. Dr. Arjomand graduated from Shahid Beheshti University of Medical Sciences in 1987. Dr. Arjomand holds New York license 221969.

Dr. Arjomand's primary practice is Newyork-Presbyterian Medical Group/Westchester, at 2649 Strang Blvd, Yorktown Heights, NY 10598 in Westchester County. The practice phone is (646) 745-6369.

Dr. Arjomand's primary practice is Newyork-Presbyterian Medical Group/Westchester in Yorktown Heights, New York. Dr. Arjomand is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is NewYork-Presbyterian Medical Group Westchester. Dmand AI also links Dr. Arjomand to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arjomand practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Arjomand's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Arjomand is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Arjomand's licenses on file in 3 states: New York, California and Pennsylvania.

CMS data shows 2,427 Medicare services from Dr. Arjomand across 14 procedure codes in 2024, for 521 Medicare patients. Medicare paid $162,869 for them.

CMS counts 521 Medicare patients who saw Dr. Arjomand in 2024. The largest group is 75 to 84, with 208 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arjomand's median patient age at 69, with 55% women.

In 2024, Dr. Arjomand wrote 4,518 Medicare Part D claims for 673 patients. 45% of them were for generic drugs. CMS names the drug for 4,351 of them, across 41 drugs with 11 or more claims each, at $1,064,832 in total drug cost. In 2023, CMS named 3,773 claims across 42 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Arjomand for performance year 2024, reported through an alternative payment model (APM). Dr. Arjomand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Arjomand as offering telehealth.

Dmand AI links 9 papers to Dr. Arjomand, published from 2010 to 2016. 2010 was the busiest year, with 2. The most frequent topics are Radiography, Thoracic and Tomography, X-Ray Computed. Dr. Arjomand's most frequent co-authors are Sasikanth Nallagatla, MD, Viswanath Parameswar Vasudevan, MD and Zary Hashemi, MD.

CMS Open Payments shows 76 general payments to Dr. Arjomand from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $510.

Dmand AI lists 1 award for Dr. Arjomand, most recently CMS Stage 1 EHR in 2013.

Dr. Arjomand graduated from Shahid Beheshti University of Medical Sciences in 1987.

Dr. Arjomand is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.